Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Efficiency of the Hepatitis B Sci-B-Vac Vaccine in HIV Positive Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2011 by Tel-Aviv Sourasky Medical Center.
Recruitment status was  Not yet recruiting
Sponsor:
Collaborator:
SciGen, Israel, the vaccine manufacturer, will be providing 300 Sci-B-Vac doses
Information provided by (Responsible Party):
Tel-Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier:
NCT01437475
First received: September 19, 2011
Last updated: October 5, 2011
Last verified: October 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: November 2013
  Estimated Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)